Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteomark comparable to DEXA:

This article was originally published in Clinica

Executive Summary

Ostex International's bone resorption test Osteomark gave comparable measurements to an existing osteoporosis test, DEXA, in a 653-patient study published in the Journal of Bone and Mineral Research (March 1996). The study found that women with high bone turnover are more likely to lose bone over time, left untreated, than those with low turnover. The data also demonstrated that bone turnover increases prior to the menopause and remains accelerated in post-menopausal years. These findings suggest, say Ostex, that Osteomark could play an effective role in the early assessment of osteoporotic risk in post-menopausal women.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel